Registration is closed. The webinar recording will be viewable in 48 hours.

Email address*

*First name

*Last name

*Organization Name

*Country or region

*State or Province

*City

*Job role

*Industry

Area of interest

*Please select one...

I wish to receive updates and announcements from CAS

I don’t wish to receive updates, announcements, and research from CAS

address1

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Your privacy is important to CAS. More detail about how we use your information is in our privacy policy.

On Demand

60min

Featured Solution:

STN IP Protection Suite STN IP Protection Suite

This webinar aired on

Antibody-drug conjugates (ADCs) are among the most promising drug classes in oncology. The ADC research landscape is rapidly evolving, driven by advancements in antibody engineering, linker technology, payload development and diversification, and more. These new innovations are reshaping the promise of ADCs.. However, they also present challenges for innovators and drug developers seeking to understand the complex and competitive intellectual property (IP) landscape.

In this webinar, experts will explore the latest trends in ADC innovation and the complications of understanding the IP landscape in this area. They will highlight the critical importance of staying up to date with evolving R&D trends and patent filings to determine freedom to operate, protect complex innovations, and maximize ROI. 

What you will learn

The evolving global research and IP landscape of antibody-drug conjugates. 
Unique challenges of developing ADC therapeutics.
The competitive landscape and complex patent claims for related technologies. 
Strategies for a comprehensive IP search to inform investment and protect your innovations.
Insights into how CAS content and solutions can enable innovators and IP professionals.